This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Texas Biomedical Research Institute, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of California. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 3,699 
1 out of 16,048 
Years Active: 2015
Title: Dean Ehrdman: Innovator in Adenovirus Research
Introduction
Dean Ehrdman is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of virology, particularly in the study of adenoviruses. His work has implications for both detection and treatment of viral infections.
Latest Patents
Ehrdman holds a patent related to adenoviruses, specifically titled "Adenoviruses and their use." This patent describes Baboon Adenovirus (BaAdV)-2/4 and BaAdV-3, detailing polynucleotides, polypeptides, and antibodies that specifically bind to these viruses. The patent also outlines methods for detecting BaAdV-2/4 and BaAdV-3, as well as strategies for treating, preventing, and inducing an immune response to these adenoviruses. Additionally, kits for these purposes are provided.
Career Highlights
Throughout his career, Dean Ehrdman has worked with prestigious institutions, including the University of California and the United States Department of Health and Human Services. His research has contributed to advancements in the understanding and management of adenoviral infections.
Collaborations
Ehrdman has collaborated with notable colleagues such as Charles Chiu and Jean Patterson. Their combined expertise has furthered research in the field of adenoviruses.
Conclusion
Dean Ehrdman's innovative work in adenovirus research has led to valuable patents and collaborations that enhance our understanding of viral infections. His contributions are significant in the ongoing efforts to develop effective detection and treatment methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile